Efficiency of three surgical procedures in eliminating high-risk human papillomavirus infection in women with precancerous cervical lesions

European Journal of Gynaecological Oncology

Volumn 27, Issue 3, 2006, Pages 239-242

  Jancar N ^a   Rakar, S ^a   Poljak, M ^b   Fujs, K ^b   Kocjan, B J ^b   Vrtacnik Bokal E ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Follow up; Human papillomavirus; Precancerous cervical lesions; Surgical treatment

Indexed keywords

ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENOTYPE; HIGH RISK PATIENT; HISTOLOGY; HUMAN; LASER; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRECANCER; SURGICAL TECHNIQUE; UTERINE CERVIX CANCER; UTERINE CERVIX CONIZATION; UTERINE CERVIX TUMOR; VAPORIZATION; VIRUS INFECTION; WART VIRUS;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CONIZATION; FEMALE; GENOTYPE; HUMANS; LASER SURGERY; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; UTERINE CERVICAL NEOPLASMS;

EID: 33745462689     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Ponten J., Adami H.O., Bergstrom R., Dillner J., Friberg L.G., Gustafsson L. et al.: "Strategies for global control of cervical cancer". Int. J. Cancer, 1995, 60, 1, 1.
2. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V. et al.: "Human papillomavirus is a necessary cause of invasive cervical cancer worldwide". J. Pathol., 1999, 189, 1, 12.
3. Bosch F.X., Munoz N.: "The viral etiology of cervical cancer". Virus. Res., 2002, 89, 2, 183.
4. Lytwyn A., Sellers J.W., Mahony J.B., Daya D., Chapman W., Ellis N. et al.: "Comparison of human papillomavirus DNA testing and repeat Papanicolaou test in women with low-grade cervical cytologic abnormalities: a randomized trial. HPV Effectiveness in Lowgrade Paps (HELP) Study No. 1 Group". CMAJ, 2000, 163, 6, 701.
5. Kim J.J., Wright T.C., Goldie S.J.: "Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance". JAMA, 2002, 287, 18, 2382.
6. Wright T.C. Jr., Cox J.T., Massad L.S., Twiggs L.B., Wilkinson E.J.: "2001 Consensus Guidelines for the management of women with cervical cytological abnormalities". JAMA, 2002, 287, 16, 2120.
7. Wright T.C. Jr., Cox J.T., Massad L.S., Carlson J., Twiggs L.B., Wilkinson E.J.: "2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia". Am. J. Obstet. Gynecol., 2003, 189, 1, 295.
8. Wright T.C. Jr., Schiffman M.: "Adding a test for human papillomavirus DNA to cervical-cancer screening". N. Engl. J. Med., 2003, 348, 6, 489.
9. Petty K.U., Menton S., Menton M., van Loenen-Frosch F., de Carvalho Gomes H., Holz B. et al.: "Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients". Br. J. Cancer., 2003, 88, 10, 1570.
10. Wright T.C. Jr., Schiffman M., Solomon D., Cox J.T., Garcia F., Goldie S. et al.: "Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening". Obstet. Gynecol., 2004, 103, 2, 304.
11. Agnantis N.J., Sotiriadis A., Paraskevaidis E.: "The current status of HPV DNA testing". Eur. J. Gynaecol. Oncol., 2003, 24, 5, 351.
12. Bodner K., Bodner-Adler B., Wierrani F., Kimberger O., Denk C., Grunberger W.: "Is therapeutic conization sufficient to eliminate a high-risk HPV infection of the uterine cervix? A clinicopathological analysis". Anticancer. Res., 2002, 22, 6B, 3733.
13. Chao A., Lin C.T., Hsueh S., Chou H.H., Chang T.C., Chen M.Y. et al.: "Usefulness of human papillomavirus testing in the follow-up of patients with high-grade cervical intraepithelial neoplasia after conization". Am. J. Obstet. Gynecol., 2004, 190, 4, 1046.
14. Elfgren K., Jacobs M., Walboomers J.M., Meijer C.J., Dillner J.: "Rate of human papillomavirus clearance after treatment of cervical intraepithelial neoplasia". Obstet. Gynecol., 2002, 100, 5 Pt 1, 965.
15. Costa S., De Simone P., Venturoli S., Cricca M., Zerbini M.L., Musiani M. et al.: "Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization". Gynecol. Oncol., 2003, 90, 2, 358.
16. Poljak M., Seme K.: "Rapid detection and typing of human papillomaviruses by consensus polymerase chain reaction and enzyme-linked immunosorbent assay". J. Virol. Methods., 1996, 56, 2, 231.
17. Poljak M., Marin I.J., Seme K., Vince A.: "Hybrid Capture II HPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail". J. Clin. Virol., 2002, 25 (suppl. 3), S89.
18. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V. et al.: "Epidemiologic classification of human papillomavirus types associated with cervical cancer". N. Engl. J. Med., 2003, 548, 6, 518.
19. Kucera E., Sliutz G., Czerwenka K., Breitenecker G., Leodolter S., Reinthaller A.: "Is high-risk human papillomavirus infection associated with cervical intraepithelial neoplasia eliminated after conization by large-loop excision of the transformation zone?". Eur. J. Obstet. Gynecol. Reprod. Biol., 2001, 100, 1, 72.
20. Houfflin Debarge V., Collinet P., Vinatier D., Ego A., Dewilde A., Boman F. et al.: "Value of human papillomavirus testing after conization by loop electrosurgical excision for high-grade squamous intraepithelial lesions". Gynecol. Oncol., 2003, 90, 3, 587.
21. Ho G.Y., Bierman R., Beardsley L., Chang C.J., Burk R.D.: "Natural history of cervicovaginal papillomavirus infection in young women". N. Engl. J. Med., 1998, 338, 7, 423.
22. Kjaer S.K., van den Brule A.J., Bock J.E., Poll P.A., Engholm G., Sherman M.E. et al.: "Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types?". Cancer. Epidemiol. Biomarkers. Prev., 1997, 6, 10, 799.
23. Franceschi S.: "The IARC commitment to cancer prevention: the example of papillomavirus and cervical cancer". Recent. Results. Cancer. Res., 2005, 166, 277.
24. Munoz N.: "Human papillomavirus and cancer: the epidemiological evidence". J. Clin. Virol., 2000, 19, 1, 1.
25. Smrkolj S., Rakar S., Mozina A., Erzen M.: "Evaluation of causes of increased incidence of cervical cancer in Slovenia". Eur. J. Obstet. Gynecol. Reprod. Biol., 2004, 117, 2, 213.
26. Vrtačnik-Bokal E., Rakar S., Možina A., Poljak M.: "Human papillomavirus infection in relation to mild dyskaryosis in conventional cervical cytology". Eur. J. Gynaecol. Oncol. 2005, 26, 1, 39.
27. Vrtačnik-Bokal E., Rakar S., Jančar N., Možina A., Poljak M.: "Role of human papillomavirus testing in reducing the number of surgical treatments for precancerous cervical lesions". Eur. J. Gynaecol. Oncol., 2005, 26, 4, 427.